Immunotherapeutic in the Cancer space focusing at a IND approval for Ovarian Cancer. Currently raising funds to support this effort.

• Presenter: Steven Blumenthal, CBO
• Commercial Catalysts: Fred Banti and Phil Crowley
• Defined Milestone: Strategically plan fund raise to support IND needs
• Targeted Completion: 5 months